Tirz Peptide
Tirz peptide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist engineered for in vitro and preclinical research applications. In laboratory settings, this 39-amino-acid peptide is evaluated for its dual-receptor activation kinetics, downstream metabolic signaling cascades, and enzymatic resistance. PX1 Research supplies high-purity research compounds strictly for non-human analytical and scientific investigation.
Quick answer
Tirz peptide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist engineered for in vitro and preclinical research applications. In laboratory settings, this 39-amino-acid peptide is evaluated for its dual-receptor activation kinetics, downstream metabolic signaling cascades, and enzymatic resistance. PX1 Research supplies high-purity research compounds strictly for non-human analytical and scientific investigation.
Key takeaways
- Tirz peptide is a synthetically derived peptide modeled after the native GIP sequence but structurally modified to bind both GIP and GLP-1 receptors.
- The primary biochemical interest in tirz peptide centers on its unbalanced dual-agonist profile.
- Preclinical studies across rodent models of metabolic dysfunction have established that dual GIP/GLP-1 receptor activation yields distinct physiological metrics compared to selective single-receptor agonists.
- To understand the unique pharmacodynamic profile of dual agonists, researchers frequently compare tirz peptide against mono-agonist and tri-agonist compounds in parallel assays.
What is Tirz Peptide? Structure and Molecular Overview
Tirz peptide is a synthetically derived peptide modeled after the native GIP sequence but structurally modified to bind both GIP and GLP-1 receptors. The peptide backbone comprises 39 amino acids and incorporates a C20 fatty diacid diacyl moiety attached via a linker to a lysine residue at position 20. This chemical modification allows the peptide to non-covalently bind to serum albumin in cell culture or animal plasma models, extending its enzymatic resistance against dipeptidyl peptidase-4 (DPP-4) clearance.
In analytical literature, the compound is categorized as a unimolecular dual incretin mimetic. Unlike native incretin hormones that possess short biological half-lives, the structural engineering of tirz peptide enables researchers to study prolonged receptor occupancy and differential intracellular signaling pathways. Laboratory investigations often utilize the GLP2-T research compound to evaluate target binding affinities, receptor endocytosis rates, and transcriptomic shifts across tissue-specific cell lines.
Dual GIP and GLP-1 Receptor Agonism Mechanism
The primary biochemical interest in tirz peptide centers on its unbalanced dual-agonist profile. In vitro receptor binding assays demonstrate that the peptide acts as a full agonist at the GIP receptor, displaying affinity comparable to endogenous GIP. Conversely, its binding affinity at the GLP-1 receptor is approximately fivefold lower than native GLP-1, demonstrating a biased signaling mechanism favor balance toward GIP pathway activation.
When engaged with target receptors on pancreatic beta-cell lines or isolated primary tissue models, tirz peptide stimulates adenylate cyclase via G-protein coupling. This leads to an intracellular accumulation of cyclic adenosine monophosphate (cAMP), triggering protein kinase A (PKA) and exchange protein directly activated by cAMP (EPAC) activation pathways. Researchers investigating dual incretin receptor agonists monitor these signals to quantify insulin secretion responses under varying glucose concentrations in controlled bioassays.
Preclinical Literature and Metabolic Research Findings
Preclinical studies across rodent models of metabolic dysfunction have established that dual GIP/GLP-1 receptor activation yields distinct physiological metrics compared to selective single-receptor agonists. In Murine models of diet-induced obesity (DIO), administration of tirz peptide resulted in significant reductions in caloric intake, marked improvements in systemic insulin sensitivity, and altered lipid metabolism markers. These outcomes are frequently detailed within the broader incretin mimetic research hub.
Cellular assays further indicate that GIP receptor signaling in adipocytes modulates lipolysis and nutrient partitioning when GLP-1 pathways are simultaneously engaged. Preclinical data suggest that co-activation of GIP pathways may protect against nutrient overload toxicity in extra-pancreatic tissues, such as hepatocytes and skeletal muscle, by optimizing fatty acid oxidation rates. Researchers continue to analyze these biochemical pathways to understand the exact synergy between GIP and GLP-1 signaling networks.
Comparative Analysis: Tirz Peptide vs. Single and Triple Incretin Agonists
To understand the unique pharmacodynamic profile of dual agonists, researchers frequently compare tirz peptide against mono-agonist and tri-agonist compounds in parallel assays. Single-target agents such as semaglutide compounds operate exclusively through GLP-1 receptor engagement, exhibiting high potency for GLP-1R signaling without directly altering GIP receptor cascades. Similarly, earlier mono-agonists like liraglutide analytical standards provide valuable baselines for assessing single-pathway receptor internalization and desensitization.
On the emerging end of the spectrum, multi-target compounds including triple-agonist compounds like retatrutide incorporate glucagon receptor (GCGR) agonism alongside GIP and GLP-1 targets. Comparative in vitro binding studies indicate that while mono-agonists like semaglutide show high GLP-1 potency, dual-acting tirz peptide balances GIP bias with GLP-1 action, and triple agonists introduce third-pathway thermogenic signaling via GCGR activation. Evaluating these three classes side by side helps research teams map how additive receptor engagement shifts downstream metabolic flux.
Laboratory Reconstitution and Handling Standards
For accurate in vitro assays, improper handling or reconstitution of tirz peptide can compromise experimental reproducibility. The compound is supplied as a lyophilized (freeze-dried) white powder requiring reconstitution with a suitable sterile solvent before use in cell culture or biochemical assays. Sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is typically selected based on the requirements of the specific assay protocol.
Reconstitution should always be performed under a laminar flow hood using strict aseptic technique. Solvent should be introduced slowly down the inner glass wall of the vial to prevent turbulent splashing, which can cause aggregation or shearing of the peptide chain. The vial should be gently swirled or rolled between the palms until complete dissolution is achieved; mechanical vortexing must be avoided to maintain molecular integrity.
Storage Protocols and Freeze-Thaw Stability
Lyophilized tirz peptide remains stable when stored in commercial laboratory freezers at -20°C to -80°C, protected from light and moisture. Desiccant packs should be kept inside storage containers to prevent ambient condensation upon removal from freezer units. Under proper desiccated, sub-zero conditions, the un-reconstituted peptide maintains chemical stability for extended periods.
Once reconstituted into aqueous solution, the working aliquot should be kept refrigerated at 2°C to 8°C if it will be consumed within a brief experimental window. For long-term study protocols, working solutions must be divided into single-use micro-aliquots and frozen at -80°C to eliminate repeated freeze-thaw cycles. Multiple freeze-thaw events lead to peptide precipitation, structural denaturation, and loss of quantifiable bioactivity in downstream assays.
Analytical Verification: RP-HPLC, Mass Spectrometry, and Endotoxin Testing
Scientific accuracy demands absolute analytical verification of all synthesized lots. High-Performance Liquid Chromatography (RP-HPLC) is utilized to measure chemical purity, ensuring that every batch of tirz peptide meets or exceeds target specifications (typically ≥99.0% purity). RP-HPLC chromatograms verify the absence of truncated synthesis sequences, oxidation products, or residual organic solvents.
Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF mass spectrometry is simultaneously conducted to confirm exact molecular mass against theoretical sequence weights. Additionally, because trace endotoxins can ruin cell viability assays and alter immune responses in animal models, strict Limulus Amebocyte Lysate (LAL) testing is performed. High-grade research lots maintain endotoxin levels well below established scientific thresholds (<0.01 EU/µg), ensuring non-interference with delicate cell cultures.
Quality Assurance, US Manufacturing, and Lot Traceability
PX1 Research prioritizes rigorous quality control across the entire supply chain. All peptides in the PX1 research catalog are synthesized within state-of-the-art, GMP-compliant manufacturing facilities located strictly in the United States. Advanced solid-phase peptide synthesis (SPPS) platforms are coupled with automated purification systems to ensure batch-to-batch consistency.
Every batch is assigned a unique lot number linked to an independent third-party Certificate of Analysis (COA) generated by an ISO 17025 accredited laboratory. Institutional buyers establishing bulk laboratory accounts receive full access to complete analytical documentation, including raw chromatograms and mass spectra. Orders are processed with same-day dispatch from domestic distribution centers in California and Arizona, minimizing transit times and cold-chain disruption risk.
Frequently Asked Questions
What is tirz peptide?
Tirz peptide is a synthetic 39-amino-acid research compound designed to act as a dual agonist at both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors for in vitro and preclinical research applications.
Is tirz peptide designated for human consumption or clinical use?
No. Tirz peptide is strictly manufactured and sold as a research compound intended exclusively for laboratory, in vitro, and non-human preclinical evaluation. It is not for human or veterinary use, medical treatment, or clinical administration.
What is the primary molecular target of tirz peptide in laboratory assays?
Tirz peptide targets the GIP receptor and GLP-1 receptor simultaneously. In cell assays, it functions as a potent agonist, triggering intracellular cAMP generation and downstream PKA signaling pathways.
How does tirz peptide differ from single GLP-1 receptor agonists?
Single GLP-1 receptor agonists activate only GLP-1 signaling, whereas tirz peptide activates both GIP and GLP-1 receptors. Preclinical data show that dual activation alters metabolic responses differently than isolated single-receptor engagement.
How should lyophilized tirz peptide be stored upon arrival?
Lyophilized tirz peptide should be stored in a dry environment at -20°C to -80°C, sealed with desiccant and protected from light, to maintain long-term peptide stability.
What solvent is recommended for reconstituting tirz peptide for in vitro studies?
Laboratory protocols typically utilize sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream cellular or enzymatic assay.
How does PX1 Research verify the purity of tirz peptide lots?
Every lot undergoes independent third-party testing at an ISO 17025 accredited laboratory using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity verification and Mass Spectrometry (MS) for molecular weight confirmation.
What is the shelf life of reconstituted tirz peptide solutions in liquid assay setups?
Reconstituted liquid solutions stored at 2°C to 8°C should generally be used within 14 to 28 days. For longer storage, solutions should be aliquoted and frozen at -80°C to prevent degradation.
Can tirz peptide be ordered in bulk for high-throughput institutional screening?
Yes, qualified institutional laboratories and researchers can establish bulk or wholesale accounts with PX1 Research to access high-volume quantities with lot-matched analytical documentation.
What shipping procedures does PX1 Research use for research peptides?
PX1 Research dispatches orders same-day Monday through Friday from fulfillment centers located in California and Arizona, using protective packaging to prevent physical and thermal stress during transit.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.